| Literature DB >> 28259248 |
Abstract
This review article describes the regulation of proprietary Chinese medicines for the Australian market, which may permit many medicines used in Traditional Chinese Medicine to have a simplified process of market access provided that certain criteria for acceptable public safety are met.Keywords: Australia; Chinese medicines; Regulation
Mesh：
Substances：
Year: 2017 PMID： 28259248 DOI： 10.1016/S1875-5364(17)30004-3
Source DB: PubMed Journal: Chin J Nat Med ISSN： 1875-5364